ABH Healthcare IPO
Market Sentiment
IPO Details
Market Lot Size
IPO Reservation
Day-wise Subscription (times subscribed)
Financial Analysis
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| Revenue | 41.39 | 49.32 | 52.59 |
| Expense | 39.19 | 41.89 | 44.66 |
| Profit (PAT) | 1.66 | 5.35 | 5.64 |
| Total Assets | 51.35 | 63.90 | 85.27 |
| Company | EPS | P/E | RoNW % | NAV | Income |
|---|---|---|---|---|---|
| Sangani Hospitals Limited | 2.17 | 24.52 | 16.20 | 23.30 | 106.96 Cr |
| Maitreya Medicare Limited | -3.64 | -34.11 | -8.10 | 42.67 | 44.85 Cr |
| Asarfi Hospital Limited | 8.47 | 27.63 | 18.65 | 49.62 | 173.50 Cr |
Promoters: Kamal Baghi, Saurabh Baghi and Vaishali Saini
Strengths & Risks
- Strong institutional (QIB) demand — 8.4x.
- Solid profit margin — 10.7%.
- Strong return on equity — 39%.
- Elevated leverage — debt/equity of 3.20.
- Lists on the exchange's SME platform, where trading is usually thinner than on the main board — selling at your price can be harder.
Compiled from this issue's live GMP, subscription, valuation and financial data, and updated as those figures change. Informational only — not investment advice. Always read the RHP before applying.
Company Information
ABH Healthcare, which operates under the brand “Anil Baghi Hospital,” is a healthcare service provider. It is a multi-speciality hospital brand that provides 25 medical specialties: cardiac sciences, neurology, minimally invasive spine and brain surgeries, medical and surgical gastroenterology, laparoscopic and bariatric surgery, urology, pulmonology, nephrology, ENT, maxillofacial surgeries, etc. ABH Healthcare offers healthcare services under various government healthcare schemes and organisations, including ECHS, Indian Railways, FCI, BSNL, and Ayushman Bharat–Sarbat Sehat Bima Yojana (ABSSBY). As of FY25, the firm includes 29 doctors and 137 nurses. Its competitive strengths are a professional management team, providing quality clinical care, modern equipment, and a track record of stable financial growth.
ABH Healthcare Ltd., Anil Baghi Road, Ferozepur,, Punjab, Firozpur, Punjab, 152002
| Purpose | Amount (Cr) |
|---|---|
| Repayment / prepayment, in part or full, of certain of our borrowings | 17.00 |
| Funding our Working Capital Requirements; and | 4.30 |
| Funding inorganic growth through unidentified acquisitions and general corporate purposes (collectively referred to as “Objects”) | - |
Resources & Documents
ABH Healthcare has set a price band of Rs 96–Rs 102 per share for an issue size of Rs 35 crore. The stock listed with a 2.94% discount versus its issue price on September 01, 2026.
ABH Healthcare, which operates under the brand “Anil Baghi Hospital,” is a healthcare service provider. It is a multi-speciality hospital brand that provides 25 medical specialties: cardiac sciences, neurology, minimally invasive spine and brain surgeries, medical and surgical gastroenterology, laparoscopic and bariatric surgery, urology, pulmonology, nephrology, ENT, maxillofacial surgeries, etc.
The issue is promoted by Kamal Baghi, Saurabh Baghi and Vaishali Saini with Fedex Securities Pvt.Ltd. acting as lead manager. Net proceeds will primarily be used towards Repayment / prepayment, in part or full, of certain of our borrowings (Rs 17 crore) and Funding our Working Capital Requirements; and (Rs 4 crore).
On fundamentals, the company is posting revenue growth of 6.6%, a profit margin of 10.7%, return on equity of 39.1% in its most recent reported period. Listed peers in this segment include Sangani Hospitals Limited (P/E 24.52x) and Maitreya Medicare Limited (P/E -34.11x) — useful reference points when evaluating the issue's pricing relative to where the broader sector are trading.
On our data-signal score, the combined signals for this issue currently read weak — several key indicators are reading below average. This is a summary of public data, not a recommendation to apply or skip. Past performance does not predict future returns — review the price chart and peer comparison below before trading.
ABH Healthcare IPO GMP — What It Means
GMP stops mattering once the shares trade — it only ever estimated the listing price. No grey market premium was recorded for ABH Healthcare before it listed.
See the full ABH Healthcare GMP history and trend, or learn how grey market premium works and how reliable it is.
Related IPO
No comments yet. Be the first to share your opinion!